AGENUS INC Stock Issued During Period, Value, Employee Benefit Plan
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- AGENUS INC stock issued during period, value, employee benefit plan for the quarter ending 2026-06-30 was $79.00K, a 102.56% increase year-over-year.
- AGENUS INC stock issued during period, value, employee benefit plan for the quarter ending 2026-03-31 was $64.00K, a 57.05% decline year-over-year.
- AGENUS INC stock issued during period, value, employee benefit plan for the quarter ending 2025-06-30 was $39.00K.
- AGENUS INC stock issued during period, value, employee benefit plan for the quarter ending 2025-03-31 was $149.00K.
- AGENUS INC stock issued during period, value, employee benefit plan for fiscal 2025 was $187.00K.
- AGENUS INC stock issued during period, value, employee benefit plan for fiscal 2023 was $3.23M, a 7.16% increase from fiscal 2022.
- AGENUS INC stock issued during period, value, employee benefit plan for fiscal 2022 was $3.02M, a 104.13% increase from fiscal 2021.
- AGENUS INC stock issued during period, value, employee benefit plan for fiscal 2021 was $1.48M.
| Period end | Stock Issued During Period, Value, Employee Benefit Plan 3 month | Stock Issued During Period, Value, Employee Benefit Plan 12 month |
|---|---|---|
| 2026-06-30 | $79.00K 10-Q · filed 2026-08-07 | |
| 2026-03-31 | $64.00K 10-Q · filed 2026-08-07 | |
| 2025-12-31 | $187.00K 10-K · filed 2026-03-16 | |
| 2025-06-30 | $39.00K 10-Q · filed 2026-08-07 | |
| 2025-03-31 | $149.00K 10-Q · filed 2026-08-07 | |
| 2023-12-31 | $3.23M 10-K · filed 2025-03-17 | |
| 2023-06-30 | $1.44M 10-Q · filed 2024-11-12 | |
| 2023-03-31 | $1.80M 10-Q · filed 2024-11-12 | |
| 2022-12-31 | $3.02M 10-K · filed 2025-03-17 | |
| 2022-06-30 | $114.00K 10-Q · filed 2023-11-09 | |
| 2022-03-31 | $2.90M 10-Q · filed 2023-11-09 | |
| 2021-12-31 | $1.48M 10-K · filed 2024-03-14 | |
| 2021-09-30 | $202.00K 10-Q · filed 2022-11-08 | |
| 2021-06-30 | $1.27M 10-Q · filed 2022-11-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| C4 Therapeutics, Inc. (CCCC) | United States | $0.373B | -5.65 |
| FENNEC PHARMACEUTICALS INC. (FENC) | United States | $0.371B | -115.85 |
| Surrozen, Inc./DE (SRZN) | United States | $0.395B | |
| Zura Bio Ltd (ZURA) | $0.398B | -6.56 | |
| Artiva Biotherapeutics, Inc. (ARTV) | United States | $0.367B | |
| Cabaletta Bio, Inc. (CABA) | United States | $0.365B | -2.81 |
| Scribe Therapeutics, Inc. (SCTX) | United States | $0.410B | |
| Ocugen, Inc. (OCGN) | United States | $0.343B | -6.34 |
| Editas Medicine, Inc. (EDIT) | United States | $0.424B | -4.29 |
| Kyverna Therapeutics, Inc. (KYTX) | United States | $0.434B | -3.60 |